Although RICTOR aberrations did not affect survival in the entire TCGA cohort, in both PIK3CA amplified and EGFR amplified HNSCC tumor subsets, there is a trend toward a shorter time to relapse in cases with RICTOR aberrations versus in those without (Fig. 1D). This evidence concerns the gene EGFR and head and neck squamous cell carcinoma.